ATE462013T1 - Verfahren zur kultivierung von zellen zur produktion von substanzen - Google Patents

Verfahren zur kultivierung von zellen zur produktion von substanzen

Info

Publication number
ATE462013T1
ATE462013T1 AT03767406T AT03767406T ATE462013T1 AT E462013 T1 ATE462013 T1 AT E462013T1 AT 03767406 T AT03767406 T AT 03767406T AT 03767406 T AT03767406 T AT 03767406T AT E462013 T1 ATE462013 T1 AT E462013T1
Authority
AT
Austria
Prior art keywords
glucose
limitation
dgl
cells
qglc
Prior art date
Application number
AT03767406T
Other languages
German (de)
English (en)
Inventor
Thomas Link
Ruth Essers
Kerstin Skopnik
Jochen Gaetgens
Thomas Noll
Christian Wandrey
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE462013T1 publication Critical patent/ATE462013T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03767406T 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen ATE462013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255508A DE10255508A1 (de) 2002-11-27 2002-11-27 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
PCT/DE2003/003693 WO2004048556A1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen

Publications (1)

Publication Number Publication Date
ATE462013T1 true ATE462013T1 (de) 2010-04-15

Family

ID=32318751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767406T ATE462013T1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen

Country Status (12)

Country Link
US (2) US20060127975A1 (enExample)
EP (3) EP1585810B1 (enExample)
JP (2) JP4469283B2 (enExample)
AT (1) ATE462013T1 (enExample)
CY (2) CY1110267T1 (enExample)
DE (2) DE10255508A1 (enExample)
DK (2) DK1585810T3 (enExample)
ES (3) ES2749217T3 (enExample)
HU (1) HUE028862T2 (enExample)
PT (1) PT1585810E (enExample)
SI (3) SI2226381T1 (enExample)
WO (1) WO2004048556A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2284271C (en) 1997-03-21 2012-05-08 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
SI1623019T1 (sl) * 2003-05-15 2010-10-29 Wyeth Llc Omejeno glukozno dovajanje za živalsko celično kulturo
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
AU2016210748B2 (en) * 2009-10-26 2018-03-01 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
ES2981683T3 (es) * 2009-10-26 2024-10-10 Hoffmann La Roche Procedimiento para la producción de una inmunoglobulina glucosilada
AU2015203309B2 (en) * 2009-10-26 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
TWI563090B (en) * 2009-12-22 2016-12-21 Dsm Ip Assets Bv The preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process
KR20130086628A (ko) 2010-11-08 2013-08-02 제넨테크, 인크. 피하 투여용 항―il―6 수용체 항체
JP6563910B2 (ja) 2013-07-04 2019-08-21 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
EP3119876B1 (en) 2014-03-19 2024-12-18 Pfizer Inc. Method of cell culture
ES2989780T3 (es) 2015-09-23 2024-11-27 Pfizer Células y procedimiento de cultivo celular
US20220073942A1 (en) 2018-12-06 2022-03-10 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657863A (en) * 1982-07-02 1987-04-14 Celanese Corporation Stabilization of a mutant microorganism population
JPH066054B2 (ja) * 1987-10-15 1994-01-26 帝人株式会社 動物細胞の培養方法
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
CA2111561A1 (en) 1992-05-01 1993-11-11 Yoshiharu Takazawa Fed batch culture method for protein secreting cells
GB9506249D0 (en) * 1995-03-27 1995-05-17 Karobio Ab Media for insect cell cultures
US6156570A (en) * 1997-03-20 2000-12-05 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6338964B1 (en) * 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration

Also Published As

Publication number Publication date
US20140329277A1 (en) 2014-11-06
SI2226381T1 (sl) 2016-05-31
SI2275530T1 (sl) 2019-11-29
ES2340377T3 (es) 2010-06-02
ES2567161T3 (es) 2016-04-20
EP2275530A2 (de) 2011-01-19
CY1117558T1 (el) 2017-04-26
DE10255508A1 (de) 2004-06-17
EP2226381B1 (de) 2016-03-09
WO2004048556A1 (de) 2004-06-10
EP1585810B1 (de) 2010-03-24
EP2275530A3 (de) 2012-05-23
JP2010110331A (ja) 2010-05-20
CY1110267T1 (el) 2015-01-14
SI1585810T1 (sl) 2010-06-30
PT1585810E (pt) 2010-05-05
EP2275530B1 (de) 2019-08-07
EP1585810A1 (de) 2005-10-19
DK2226381T3 (en) 2016-04-11
JP2006507821A (ja) 2006-03-09
ES2749217T3 (es) 2020-03-19
HUE028862T2 (en) 2017-01-30
DK1585810T3 (da) 2010-06-07
JP5221573B2 (ja) 2013-06-26
DE50312554D1 (de) 2010-05-06
US20060127975A1 (en) 2006-06-15
EP2226381A1 (de) 2010-09-08
JP4469283B2 (ja) 2010-05-26

Similar Documents

Publication Publication Date Title
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
EP1239041A3 (en) Method for producing L-amino acid using bacteria belonging to the genus Escherichia
ATE493502T1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
ATE367436T1 (de) Verfahren und materialien zur produktion von d- milchsäure in hefe
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
BRPI0516261A (pt) método para produzir uma substãncia básica por fermentação, e, caldo de fermentação ou produto de fermentação contendo uma substáncia básica
ATE361360T1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
DE60138127D1 (de) Stoffwechseländerungen in gärungen zur produktion rekombinanter proteine
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
DK1495112T3 (da) Cellekulturmedium
DE60319599D1 (de) Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle eine neurodegenerative krankheit
DE50211123D1 (de) Verfahren zur kultivierung von zellen, insbesondere menschlicher oder tierischer zellen
ATE521697T1 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
ATE254183T1 (de) Verfahren zur herstellung von exopolysaccharide
ATE349513T1 (de) Verfahren zur homogenen masskultivierung von t- lymphozyten
WO2004013333A3 (de) Revertierung der negativ-selektiven wirkung von negativen markerproteinen als selektionsverfahren
ATE357532T1 (de) Verfahren zur herstellung von l-lysin unter verwendung coryneformer bakterien die ein attenuiertes malat enzym-gen enthalten
ATE413451T1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
ATE384790T1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
AU2003242533A1 (en) Glutamine-free medium
ATE522615T1 (de) Verfahren zur kontrolle eines zellulären prozesses in einem multi-zellulären organismus